Reata Pharmaceuticals Inc buy melinda
Summary
This prediction is currently being closed. The BUY prediction by melinda for Reata Pharmaceuticals Inc has seen massive gains of 87.36%. melinda has 20% into this predictionReata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on identifying, developing, and commercializing novel therapeutics for patients with severe and life-threatening diseases. The company's primary business areas include drug discovery and development in fields such as cardiovascular, fibrotic, mitochondrial, and neurodegenerative diseases. With a strong emphasis on research and innovation, Reata Pharmaceuticals seeks to deliver cutting-edge treatments that address unmet medical needs, improve patient outcomes, and significantly impact the lives of those suffering from rare and debilitating conditions. As a publicly traded company, Reata Pharmaceuticals is listed on the NASDAQ stock exchange under the ticker symbol "RETA."
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Reata Pharmaceuticals Inc | - | - | - |
iShares Core DAX® | 1.164% | 1.549% | 24.351% |
iShares Nasdaq 100 | 0.118% | 0.969% | 28.865% |
iShares Nikkei 225® | 1.124% | -1.120% | 17.443% |
iShares S&P 500 | 0.479% | 1.068% | 28.585% |
Comments by melinda for this prediction
In the thread Reata Pharmaceuticals Inc diskutieren
In the thread Trading Reata Pharmaceuticals Inc
Stopped prediction by melinda for Reata Pharmaceuticals Inc
Reata Pharmaceuticals Inc
11.04.18
20.04.18
20.04.18